mikeyuk
Active Member
- Messages
- 43
- Location
- Northern Ireland
Unfortunately for the authors, too late for their paper, the Accord researchers have now analysed and revised their findings.The commentary says that this study although it supports the results of RCT’s such as ACCORD cannot show as causal relationship between HBA1c and mortality. However the results are consistent with the idea that premature death may be related to hypoglycaemia.
.Various characteristics of the participants and the study sites at baseline had significant associations with the risk of mortality. Before and after adjustment for these covariates, a higher average on-treatment A1C was a stronger predictor of mortality than the A1C for the last interval of follow-up or the decrease of A1C in the first year. Higher average A1C was associated with greater risk of death. The risk of death with the intensive strategy increased approximately linearly from 6–9% A1C and appeared to be greater with the intensive than with the standard strategy only when average A1C was >7%.
CONCLUSIONS These analyses implicate factors associated with persisting higher A1C levels, rather than low A1C per se, as likely contributors to the increased mortality risk associated with the intensive glycemic treatment strategy in ACCORD
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?